By the same authors

From the same journal

The clinical impact of staging bone marrow examination on treatment decisions and prognostic assessment of lymphoma patients

Research output: Contribution to journalArticle

Published copy (DOI)



Publication details

JournalBritish Journal of Haematology
DateE-pub ahead of print - 29 Apr 2015
DatePublished (current) - Apr 2015
Early online date29/04/15
Original languageEnglish


This study investigates the value of performing a staging bone marrow in patients with diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and classical hodgkin lymphoma (CHL). The results of 3112 staging bone marrow examinations were assessed for impact on prognostic assessment and critical treatment decisions. The detection of marrow involvement altered the disease-specific prognostic index for 4·3% of DLBCL, 6·2% of FL and 0·6% of CHL but marrow involvement in DLBCL was an independent prognostic factor. Knowing the marrow status potentially changed treatment in 92 patients, detection of these patients would have required 854 examinations to be performed.

Bibliographical note

© 2015 John Wiley & Sons Ltd.

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations